2024-2029 US Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

November 2024 | | ID: 2D797C5CF96FEN
Venture Planning Group

Abstracts

About This ReportThis new LeadingMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.In addition to market share and sales forecasts, the report:- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for STD testing;- Profiles key suppliers and potential market entrants developing innovative technologies and products and-  Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch's proprietary data files was conducted.List of TablesMajor Companies Developing or Marketing Chlamydia Tests

Major Companies Developing or Marketing Gonorrhea Tests

Major Companies Developing or Marketing Herpes Tests

Major Companies Developing or Marketing Pap Smear/HPV Tests

Major Companies Developing or Marketing Syphilis Tests

U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Chancroid Diagnostics Sales by Major Supplier

U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Chlamydia Diagnostics Sales by Major Supplier

U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier

U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment

U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A.
PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment

U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier

Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests

1. CHANCROID

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

2. CHLAMYDIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

3. GONORRHEA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

4. HERPES SIMPLEX VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

5. PAPILLOMAVIRUS (HPV)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

6. SYPHILIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens
Healthineers, Tosoh, and Other Suppliers
C. Emerging Diagnostic Technologies

1. MOLECULAR DIAGNOSTICS

2. MONOCLONAL ANTIBODIES

3. IMMUNOASSAYS

4. DIFFERENTIAL LIGHT SCATTERING

5. INFORMATION TECHNOLOGY

6. ARTIFICIAL INTELLIGENCE

7. LIPOSOMES

8. FLOW CYTOMETRY

9. CHROMATOGRAPHY

10. DIAGNOSTIC IMAGING

11. GEL MICRODROPLETS

12. OTHER

III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS

5. EMERGING SUPPLIERS

6. MAJOR TYPES OF DISTRIBUTORS

7. MARKET SEGMENTATION

Table of Contents (continued)
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako